US 12268720
Bacteriophage for treatment and prevention of E. coli and B. fragilis infections
granted A61KA61K35/76A61K35/768
Quick answer
US patent 12268720 (Bacteriophage for treatment and prevention of E. coli and B. fragilis infections) held by Armata Pharmaceuticals, Inc. expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Armata Pharmaceuticals, Inc.
- Grant date
- Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K35/76, A61K35/768, A61K39/12, A61K45/06